Pulmonary Embolism in Pregnancy: Biomarkers and Clinical Predictive Models

March 10, 2016 updated by: Barbara Parilla, MD, Advocate Health Care

Diagnosing Pulmonary Embolism in Pregnancy: Are Biomarkers and Clinical Prediction Models Useful?

Objective: To evaluate whether trimester specific d-dimer levels and brain natriuretic protein (BNP), along with the modified Wells score (MWS), is a useful risk stratification tool to exclude pregnant women at low-risk of pulmonary embolism (PE) from diagnostic imaging with radiation exposure.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

To account for all women meeting the study eligibility criteria, this study utilized a combined prospective and retrospective arm. Pregnant women who underwent diagnostic imaging to evaluate for suspected PE at our institution were prospectively enrolled from February 2014 to August 2015. Both d-dimer and BNP serum levels were drawn, and a MWS was assigned. All pregnant women diagnosed with a PE that underwent diagnostic imaging and had a d-dimer level drawn from January 2009 to June 2014 were retrospectively enrolled. Patient electronic records were used to apply the MWS and analyze their risk.

Study Type

Observational

Enrollment (Actual)

59

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

pregnant women who presented to the Emergency Department or Labor and Delivery unit with signs and symptoms suspicious for PE

Description

Inclusion criteria:

  • adult pregnant women >= 18 years old
  • d-dimer obtained and if the patient was pregnant at the time of PE diagnosis
  • patient presented to the Emergency Department or Labor and Delivery unit
  • patient presented with signs and symptoms suspicious for PE

Exclusion criteria:

  • non-pregnant patients
  • patients < 18 years old

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
pregnant with pulmonary embolism
Pregnant women who underwent diagnostic imaging to evaluate for suspected PE at our institution
blood draw
pregnant without pulmonary embolism
Pregnant women who underwent diagnostic imaging to evaluate for suspected PE at our institution

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Serum D-dimer levels (ug/ml)
Time Frame: 18 months
Trimester specific D-dimer levels to identify pregnant women at low risk for pulmonary embolism, thereby avoiding radiation exposure
18 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Modified Well's Criteria- a risk scoring system for likelihood of pulmonary embolism
Time Frame: 18 months
A Modified Wells score of >4 suggests pulmonary embolism is likely and therefore diagnostic imaging needed
18 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2014

Primary Completion (Actual)

August 1, 2015

Study Completion (Actual)

August 1, 2015

Study Registration Dates

First Submitted

August 19, 2015

First Submitted That Met QC Criteria

March 10, 2016

First Posted (Estimate)

March 15, 2016

Study Record Updates

Last Update Posted (Estimate)

March 15, 2016

Last Update Submitted That Met QC Criteria

March 10, 2016

Last Verified

March 1, 2016

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pulmonary Embolism

Clinical Trials on blood draw

3
Subscribe